Taken together, these results suggest that the TonEBP may transcriptionally regulate systemic and neuroinflammation via the direct binding to position − 2827 of the LCN2 promoter region under diabetic conditions of low-grade inflammation and hyperglycemia. Here, NFAT5 is linked to Hyperglycemia.